Skip to main content
SpringerLink
Log in

Aging, Immunity and Cancer

  • Chapter
Handbook on Immunosenescence

Abstract

Although the increased incidence of common cancers with age on one hand and immunosenescence on the other are both well documented in animal models and in humans, evidence for a causal link between the two is controversial. It is, therefore, most appropriate to critically consider whether the dysfunctional immune processes occurring with aging may play a contributing role in the increased incidence of cancer with aging. Indeed whether or not immunosenescence plays a significant role could have a determinant impact on devising cancer prevention and/or immunotherapeutic strategies for the presently growing elderly population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abe M, Kondo S, Hirano S, Ambo Y, Tanaka E, Morikawa T, Okushiba S and Katoh H (2003) Long-term survival after radical resection of advanced pancreatic cancer: a case report with special reference to CD8+ T-cell infiltration. Int J Gastrointest Cancer 33:107–110

    Article  PubMed  Google Scholar 

  • Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M, Paradise C, Kunkel L and Rosenberg SA (1999) High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 17:2105–2116

    PubMed  CAS  Google Scholar 

  • Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S and Gress R (2004) Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. J Clin Oncol 22:3886–3892

    Article  PubMed  Google Scholar 

  • Bonafe M, Barbi C, Storci G, Salvioli S, Capri M, Olivieri F, Valensin S, Monti D, Gonos ES, De BG and Franceschi C (2002) What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians. Exp Gerontol 37:1263–1271

    Article  PubMed  CAS  Google Scholar 

  • Bronte V, Cingarlini S, Marigo I, De Santo C, Gallina G, Dolcetti L, Ugel S, Peranzoni E, Mandruzzato S and Zanovello P (2006) Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. Immunol Invest 35:327–357

    Article  PubMed  CAS  Google Scholar 

  • Bruunsgaard H (2006) The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. Dan Med Bull 53:285–309

    PubMed  Google Scholar 

  • Buell JF, Gross TG and Woodle ES (2005) Malignancy after transplantation. Transplantation 80:S254–S264

    Article  PubMed  Google Scholar 

  • Cameron AJ, Lomboy CT, Pera M and Carpenter HA (1995) Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology 109:1541–1546

    Article  PubMed  CAS  Google Scholar 

  • Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, Ohuchi A, Ohuchi K, Shiiba K, Kurokawa Y and Satomi S (2004) Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer 91:1711–1717

    PubMed  CAS  Google Scholar 

  • Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS and Barrett AJ (2000) Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 343:750–758

    Article  PubMed  CAS  Google Scholar 

  • Cho Y, Miyamoto M, Kato K, Fukunaga A, Shichinohe T, Kawarada Y, Hida Y, Oshikiri T, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Murakami S, Shinohara T, Itoh T, Okushiba S, Kondo S and Katoh H (2003) CD4 +and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 63:1555–1559

    PubMed  CAS  Google Scholar 

  • Cui Z and Willingham MC (2004) The effect of aging on cellular immunity against cancer in SR/ CR mice. Cancer Immunol Immunother 53:473–478

    Article  PubMed  Google Scholar 

  • Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, Hawkins GA, Miller MS, Weir HM, Du W and DeLong CJ (2003) Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci U S A 100:6682–6687

    Article  PubMed  CAS  Google Scholar 

  • D’Arminio Monforte A, Abrams D, Pradier C, Weber R, Bonnet F, De Wit S, Friis-Moller N, Phillips A, Sabin C and Lundgren J (2007) HIV-induced Immunodeficiency and Risk of Fatal AIDS-defining and Non-AIDS-defining Malignancies: Results from the D:A:D Study. 14th Conference on retroviruses and opportunistic infections

    Google Scholar 

  • de Visser KE and Coussens LM (2006) The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13:118–137

    Article  PubMed  Google Scholar 

  • de Visser KE, Korets LV and Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411–423

    Article  PubMed  CAS  Google Scholar 

  • Donato F, Boffetta P and Puoti M (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75:347–354

    Article  PubMed  CAS  Google Scholar 

  • Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A and Rosenberg SA (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23:2346–2357

    Article  PubMed  CAS  Google Scholar 

  • Dunn GP, Koebel CM and Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836–848

    Article  PubMed  CAS  Google Scholar 

  • Dunn GP, Old LJ and Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329–360

    Article  PubMed  CAS  Google Scholar 

  • Eaden JA, Abrams KR and Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gu t 48:526–535

    CAS  Google Scholar 

  • Engel AM, Svane IM, Rygaard J and Werdelin O (1997) MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice. Scand J Immunol 45:463–470

    Article  PubMed  CAS  Google Scholar 

  • Enzler T, Gillessen S, Manis JP, Ferguson D, Fleming J, Alt FW, Mihm M and Dranoff G (2003) Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med 197:1213–1219

    Article  PubMed  CAS  Google Scholar 

  • Ernst PB and Gold BD (2000) The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54:615–640

    Article  PubMed  CAS  Google Scholar 

  • Gattinoni L, Powell DJ Jr., Rosenberg SA and Restifo NP (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6:383–393

    Article  PubMed  CAS  Google Scholar 

  • Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M and Weinberg A (1997) Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158:977–983

    PubMed  CAS  Google Scholar 

  • Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, Nakakubo Y, Itoh T, Ohbuchi T, Kondo S and Katoh H (2006) Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 94:275–280

    Article  PubMed  CAS  Google Scholar 

  • Imai K, Matsuyama S, Miyake S, Suga K and Nakachi K (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356:1795–1799

    Article  PubMed  CAS  Google Scholar 

  • Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ and Schreiber RD (1998) Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 95:7556–7561

    Article  PubMed  CAS  Google Scholar 

  • Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431–436

    Article  PubMed  CAS  Google Scholar 

  • Karin M and Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–759

    Article  PubMed  CAS  Google Scholar 

  • Lin EY and Pollard JW (2004a) Macrophages: modulators of breast cancer progression. Novartis Found Symp 256:158–168

    Article  CAS  Google Scholar 

  • Lin EY and Pollard JW (2004b) Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90:2053–2058

    Article  CAS  Google Scholar 

  • Lin WW and Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175–1183

    Article  PubMed  CAS  Google Scholar 

  • Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH and O’Reilly RJ (1995b) Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response? Bone Marrow Transplant 15:591–594

    CAS  Google Scholar 

  • Manning CB, Vallyathan V and Mossman BT (2002) Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2:191–200

    Article  PubMed  CAS  Google Scholar 

  • Miller RA and Chrisp C (2002) T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice. J Immunol 169:1619–1625

    PubMed  CAS  Google Scholar 

  • Miyaishi O, Ando F, Matsuzawa K, Kanawa R and Isobe K (2000) Cancer incidence in old age. Mech Ageing Dev 117:47–55

    Article  PubMed  CAS  Google Scholar 

  • Nakakubo Y, Miyamoto M, Cho Y, Hida Y, Oshikiri T, Suzuoki M, Hiraoka K, Itoh T, Kondo S and Katoh H (2003). Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer 89:1736–1742

    Article  PubMed  CAS  Google Scholar 

  • Ochs HD, Smith CIE and Puck JM (2006) In: Ochs HD, Smith CIE and Puck JM (eds) Primary immunodeficiency diseases: a molecular and genetic approach. Oxford University Press

    Google Scholar 

  • Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH and Galon J (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654–2666

    Article  PubMed  CAS  Google Scholar 

  • Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, Muranski P, Sanchez-Perez L, Palmer DC, Yu Z, Antony PA, Gattinoni L, Rosenberg SA and Restifo NP (2007) Toll-like receptors in tumor immunotherapy. Clin Cancer Res 13:5280–5289

    Article  PubMed  CAS  Google Scholar 

  • Penn I (1995) Sarcomas in organ allograft recipients. Transplantation 60:1485–1491

    Article  PubMed  CAS  Google Scholar 

  • Penn I (1996) Malignant melanoma in organ allograft recipients. Transplantation 61:274–278

    Article  PubMed  CAS  Google Scholar 

  • Peto R, Roe FJ, Lee PN, Levy L and Clack J (1975) Cancer and ageing in mice and men. Br J Cancer 32:411–426

    PubMed  CAS  Google Scholar 

  • Pham SM, Kormos RL, Landreneau RJ, Kawai A, Gonzalez-Cancel I, Hardesty RL, Hattler BG and Griffith BP (1995) Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 60:1623–1626

    Article  PubMed  CAS  Google Scholar 

  • Phan GQ, Attia P, Steinberg SM, White DE and Rosenberg SA (2001) Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. J Clin Oncol 19:3477–3482

    PubMed  CAS  Google Scholar 

  • Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78

    Article  PubMed  CAS  Google Scholar 

  • Porter DL Roth MS, Mcgarigle C, Ferrara JLM and Antin JH (1994) Induction of Graft-Versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia. N Engl J Med 330:100–106

    Article  PubMed  CAS  Google Scholar 

  • Provinciali M, Smorlesi A, Donnini A, Bartozzi B and Amici A (2003) Low effectiveness of DNA vaccination against HER-2/neu in ageing. Vaccine 21:843–848

    Article  PubMed  CAS  Google Scholar 

  • Reed MJ, Karres N, Eyman D, Cruz A, Brekken RA and Plymate S (2007). The effects of aging on tumor growth and angiogenesis are tumor-cell dependent. Int J Cancer 120:753–760

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg SA (2000). Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer. Cancer J Sci Am 6 Suppl 1:S2–S7

    PubMed  Google Scholar 

  • Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ and Schreiber RD (2001) IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107–1111

    Article  PubMed  CAS  Google Scholar 

  • Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI and Trapani JA (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755–760

    Article  PubMed  CAS  Google Scholar 

  • Stanta G, Campagner L, Cavallieri F and Giarelli L (1997) Cancer of the oldest old. What we have learned from autopsy studies. Clin Geriatr Med 13:55–68

    PubMed  CAS  Google Scholar 

  • Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK and Levin B (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952

    Article  PubMed  CAS  Google Scholar 

  • Street SE, Trapani JA, MacGregor D and Smyth MJ (2002) Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 196:129–134

    Article  PubMed  CAS  Google Scholar 

  • Stutman O (1974) Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 183:534–536

    Article  PubMed  CAS  Google Scholar 

  • Sullivan KE, Mullen CA, Blaese RM and Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885

    Article  PubMed  CAS  Google Scholar 

  • Swann JB and Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117:1137–1146

    Article  PubMed  CAS  Google Scholar 

  • Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y and Sugimachi K (2001) Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol 96:574–578

    Article  PubMed  CAS  Google Scholar 

  • Tracey KJ (2002) The inflammatory reflex. Nature 420:853–859

    Article  PubMed  CAS  Google Scholar 

  • Ueno NT, Cheng YC, Rondon G, Tannir NM, Gajewski JL, Couriel DR, Hosing C, de Lima MJ, Anderlini P, Khouri IF, Booser DJ, Hortobagyi GN, Pagliaro LC, Jonasch E, Giralt SA and Champlin RE (2003) Rapid induction of complete donor chimerism by the use of a reducedintensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Blood 102:3829–3836

    Article  PubMed  CAS  Google Scholar 

  • Varan A, Buyukpamukcu M, Ersoy F, Sanal O, Akyuz C, Kutluk T and Yalcin B (2004) Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr Hematol Oncol 21:441–451

    Article  PubMed  Google Scholar 

  • Wakabayashi O, Yamazaki K, Oizumi S, Hommura F, Kinoshita I, Ogura S, aka-Akita H and Nishimura M (2003) CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 94:1003–1009

    Article  PubMed  CAS  Google Scholar 

  • Whitcomb DC (2004) Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 287:G315–G319

    Article  PubMed  CAS  Google Scholar 

  • Wilson RE, Hager EB, Hampers CL, Corson JM, Merrill JP and Murray JE (1968) Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med 278:479–483

    Article  PubMed  CAS  Google Scholar 

  • Young MR, Kolesiak K, Achille NJ, Meisinger J, Gonzalez E, Liu SW, Wrone-Smith T and Lathers DM (2001) Impact of aging on immune modulation by tumor. Cancer Immunol Immunother 50:315–320

    Article  PubMed  CAS  Google Scholar 

  • Zhang HG and Grizzle WE (2003) Aging, immunity, and tumor susceptibility. Immunol Allergy Clin North Am 23:83–102, vi

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC and Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203–213

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Transplantation ' Immunology Branch Center for Cancer Research, National Cancer Institute, 10 Center Drive, 20892-1203, Bethesda, MD

    Claude Sportès & Frances T. Hakim

Authors
  1. Claude Sportès
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frances T. Hakim
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Research Center on Aging, Department of Medicine, Immunology Graduate Programme, Faculty of Medicine, University of Sherbrooke, 1036 Rue Belvedere, J1H 4C4, Sherbrooke, Quebec, Canada

    Tamas Fulop

  2. Department of Experimental Pathalogy, CIG Interdepartmental Center “L. Galvani” University of Bologna, Via San Giacomo 12, 40126, Bologna, Italy

    Claudio Franceschi

  3. Institute for Health and Life Sciences, 4-6-22 Kohinato, Bunkyo-ku, Tokyo, 112-0006, Japan

    Katsuiku Hirokawa

  4. ZMF - Zentrum Med. Forschung Abt. Transplant./ Immunologie, University of Tübingen, Waldhörnlestr. 22, 72072, Tübingen, Germany

    Graham Pawelec

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Sportès, C., Hakim, F.T. (2009). Aging, Immunity and Cancer. In: Fulop, T., Franceschi, C., Hirokawa, K., Pawelec, G. (eds) Handbook on Immunosenescence. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9063-9_55

Download citation

Publish with us

Policies and ethics

Search

Navigation